8-K: Bolt Projects Reports Soaring Revenue, Faces Nasdaq Delisting

Bolt Projects Holdings, Inc. announced a twenty-three-fold increase in Q2 2025 Vegan Silk revenue and achieved positive gross profit ahead of schedule, but also received a Nasdaq delisting notice.

Summary

• Vegan Silk Technology Platform revenues for Q2 2025 surged to $1.3 million, a twenty-three-fold increase year-over-year from $56 thousand in Q2 2024.
• The company achieved positive gross profit of $62 thousand in Q2 2025, ahead of its internal estimate, compared to a gross loss of $29 thousand in Q2 2024.
• Net loss significantly decreased to $4.6 million in Q2 2025 from $58.9 million in Q2 2024, primarily due to the absence of bridge note issuance costs and reduced remeasurement losses.
• Basic and diluted net loss per share improved to ($2.20) in Q2 2025 from ($252.21) in Q2 2024.
• Bolt initiated gross profit guidance of $0.5 million for 2025 and $1.0 million for 2026, while maintaining full-year revenue guidance at $4.5 million for 2025 and $9.0 million for 2026.
• The company secured a non-binding term sheet for up to $20 million in financing from Ascent Partners, comprising preferred stock and an equity line of credit, subject to conditions and shareholder approval.
• Bolt received a Nasdaq delisting notice on August 12, 2025, and intends to appeal the determination and request a stay of suspension.
• Cash and cash equivalents stood at $1.0 million as of June 30, 2025, down from $3.5 million at December 31, 2024.
• Operating expenses decreased to $4.9 million in Q2 2025 from $9.6 million in Q2 2024, largely due to the absence of bridge note issuance costs.

Sentiment

Score: 4

Explanation: While operational performance shows strong growth and positive gross margins ahead of schedule, the immediate threat of Nasdaq delisting and the low cash balance, coupled with the 'going concern' warning, introduce significant financial instability and risk, outweighing the positive business momentum.

Positives

• Vegan Silk Technology Platform revenues grew twenty-three-fold year-over-year to $1.3 million in Q2 2025, demonstrating strong commercial momentum.
• Achieved positive gross profit of $62 thousand in Q2 2025, a quarter ahead of internal estimates, reflecting pricing discipline and material cost reductions.
• Secured its first brand partner from one of the seven major beauty conglomerates, indicating significant market penetration.
• A global skincare brand owned by a top beauty conglomerate plans to launch its first product featuring Bolts Vegan Silk in 2026, with additional products in development.
• Goddess Maintenance Company launched a Restorative Leave-In Hair Mask with the proprietary Goddess Molecule, expanding international distribution to over 100+ markets by October 2025.
• Net loss significantly decreased to $4.6 million in Q2 2025 from $58.9 million in Q2 2024, driven by the absence of prior year's bridge note issuance costs and reduced remeasurement losses.
• Net loss per share improved substantially to ($2.20) in Q2 2025 from ($252.21) in Q2 2024.
• Added 5 new patents in Q2 2025, bringing the total to 77 granted and 118 pending as of June 30, 2025, strengthening the intellectual property portfolio.
• Entered into a non-binding term sheet for up to $20 million in financing, providing a potential source of capital.

Negatives

• Received a notice of determination of delisting from the Nasdaq on August 12, 2025, posing a significant risk to the company's public trading status.
• Adjusted EBITDA worsened to ($3.3) million in Q2 2025 compared to ($2.6) million in Q2 2024, indicating increased operational cash burn on an adjusted basis.
• Cash and cash equivalents decreased to $1.0 million as of June 30, 2025, from $3.5 million at December 31, 2024, highlighting a low cash runway.
• The company's existing cash resources are believed to be sufficient only until anticipated financing activities are completed in Q3 2025, with no assurance that these activities will be consummated.
• The company has a history of net losses and negative cash flows, raising concerns about its long-term financial sustainability.

Risks

• Substantial doubt exists regarding the company's ability to continue as a going concern.
• The company has a history of net losses and negative cash flows.
• Uncertainty regarding the company's ability to generate sufficient cash to service its debt.
• Risk of not meeting the continued listing requirements of Nasdaq and potential delisting from a national stock exchange.
• Uncertainty regarding the company's ability to execute its business plan, adequately control expenses, or raise additional capital on favorable terms, if at all.
• Dependence on sales of b-silk and xl-silk products from its Vegan Silk Technology Platform.
• Reliance on a single or limited manufacturing partners and manufacturing facilities.
• Potential impact of U.S. trade policy, including renegotiating or terminating existing trade agreements and leveraging tariffs.
• Costs and availability for its Vegan Technology Platform products are out of the company's control.
• Market acceptance of products from consumer product companies is not guaranteed.
• Challenges in adequately protecting its patents and other intellectual property assets.
• Government regulations and private party actions relating to the marketing and advertising of cosmetic products that include the company's products.

Future Outlook

Bolt Projects forecasts revenues of at least $4.5 million for 2025 and at least $9.0 million for 2026, with gross profit guidance set at $0.5 million for 2025 and $1.0 million for 2026. The company anticipates double-digit manufacturing cost reductions in the second half of 2025. Management believes existing cash resources will be sufficient to fund planned operations until anticipated financing activities are completed in Q3 2025, though there is no assurance these financings will be consummated. A global skincare brand is expected to launch its first product featuring Bolts Vegan Silk in 2026, with additional products in development.

Management Comments

• "Demand for Vegan Silk continues to grow, resulting in positive gross margins a quarter ahead of estimate." Dan Widmaier, Chairman and CEO.
• "Our pricing discipline helped us achieve profitability on material from our last campaign, even before expected cost reductions in the next." Dan Widmaier, Chairman and CEO.
• "We believe the Vegan Silk Technology Platform delivers high-performance, sustainable benefits that meet customer needs and supports long-term growth." Dan Widmaier, Chairman and CEO.
• "Quarter by quarter, we’re building momentum for strong growth in 2026 and beyond." Cintia Nardi, President.
• "We see three demand drivers: pressure to reformulate, changing consumer expectations, and stricter rules on silicones and microplastics." Cintia Nardi, President.
• "Momentum with both indie brands and major global players gives us confidence in Bolts long-term commercial potential." Cintia Nardi, President.
• "Breaking into the top seven for the first time is a major milestone." Cintia Nardi, President.
• "We believe innovations like the Goddess Molecule show the power of our platform to deliver differentiated, scalable solutions." Dan Widmaier, CEO.
• "Seeing partners like Goddess expand globally underscores the commercial and scientific strength of our model." Dan Widmaier, CEO.
• "With our first anniversary as a public company approaching, we’re adding gross profit to our investor guidance." Cintia Nardi, President.
• "Thanks to strong Q2 results and close supplier collaboration, we expect double-digit manufacturing cost reductions in the second half of 2025." Cintia Nardi, President.
• "Lower costs and stronger margins have allowed us to offer sustainable, competitive pricing." Dan Widmaier, CEO.
• "A core part of our model is passing some of these savings to customers." Dan Widmaier, CEO.
• "Our biotech expertise and growing IP portfolio has allowed us to create novel molecules that we believe improve performance and enable proprietary claims – giving partners a competitive edge in a crowded, claims-driven market." David Breslauer, Chief Product and Technology Officer.

Industry Context

Bolt Projects operates in the biomaterials sector, specifically targeting the beauty and personal care industry with its Vegan Silk Technology Platform. The company is capitalizing on growing demand for sustainable and high-performance ingredients, driven by consumer expectations, regulatory pressures against silicones and microplastics, and brands' need to reformulate. Its success in securing a partnership with a major beauty conglomerate highlights a shift towards bioengineered solutions within the industry, positioning Bolt as a pioneer in providing eco-conscious, scientifically-driven alternatives.

Comparison to Industry Standards

• Bolt's twenty-three-fold year-over-year revenue growth for its Vegan Silk Technology Platform indicates exceptional market traction, significantly outpacing typical growth rates for established chemical or ingredient suppliers in the beauty industry.
• Achieving positive gross profit ahead of internal estimates suggests strong operational efficiency and pricing power for its biomaterials, which is a critical milestone for a company in the scaling phase of novel material production, often characterized by high initial costs.
• The partnership with a brand from one of the 'seven major beauty conglomerates' (controlling over 70% of industry revenue) is a significant validation of Bolt's technology and market acceptance, comparable to major ingredient suppliers securing contracts with industry leaders like L'Oréal, Estée Lauder, or Procter & Gamble.
• The launch of Goddess Maintenance Company's Restorative Leave-In Hair Mask, formulated with Bolt's proprietary 'Goddess Molecule,' demonstrates successful product integration and commercialization, akin to how specialized ingredient companies collaborate with indie brands to bring innovative formulations to market.
• The planned 2026 launch with a global skincare brand known for 'clinical-grade, transparent formulations' aligns Bolt with the industry trend towards clean beauty and performance-driven ingredients, similar to how companies like Givaudan or Croda develop and supply specialized actives for high-end skincare lines.

Management Changes

Corporate Governance

Legal Proceedings

• The company intends to submit a hearing request to appeal the Nasdaq delisting determination and request a stay of the suspension to remain trading pending the hearing. There is no assurance that the request for continued listing will be granted or that the company will ultimately regain compliance with applicable Nasdaq listing requirements.

Related Party Transactions

• Agreement with Southern Point Capital to convert $1.7 million in vendor payables to equity, subject to court approval and shareholder approval at the annual meeting.

Stakeholder Impact

• **Shareholders**: Potential for significant dilution from the proposed $20 million financing in preferred stock and equity line of credit, as well as the conversion of $1.7 million in vendor payables to equity. The Nasdaq delisting notice poses a severe risk to liquidity and share value, potentially moving trading to an over-the-counter market.
• **Customers**: Continued supply of high-performance, sustainable Vegan Silk products, with potential for competitive pricing due to expected manufacturing cost reductions. New product launches with major beauty conglomerates indicate expanding access to Bolt's innovative materials.
• **Employees**: Continued operations and growth in R&D and Sales & Marketing suggest ongoing employment opportunities, though the company's financial precariousness and 'going concern' risk could create uncertainty.
• **Creditors**: Southern Point Capital, as a vendor, is converting payables to equity, which could reduce the company's short-term liabilities but also indicates financial strain. Other creditors may face risks if the company's financial situation does not stabilize.

Next Steps

• Submit a hearing request to appeal the Nasdaq delisting determination and request a stay of suspension.
• Present a compliance plan at the Nasdaq hearing to regain compliance with listing requirements.
• Complete the anticipated financing activities with Ascent Partners in Q3 2025, with the first tranche planned for September 2025.
• Seek shareholder approval for the Ascent Partners financing and the conversion of vendor payables to equity at the annual meeting.
• Continue scaling production and implementing process optimization to achieve double-digit manufacturing cost reductions in the second half of 2025.
• Support the global skincare brand's planned launch of its first product featuring Bolts Vegan Silk in 2026, with additional products in development.
• Continue expanding international distribution for Goddess Maintenance Company's Restorative Leave-In Hair Mask, aiming to reach over 100+ markets by October 2025.

Key Dates

Recommendation

Despite strong operational growth in revenue and achieving positive gross profit ahead of schedule, the immediate and severe risk of Nasdaq delisting, coupled with a low cash balance and explicit 'substantial doubt as to the Company's ability to continue as a going concern,' creates an extremely high-risk investment profile. The reliance on unassured future financing and the potential loss of exchange listing outweigh the positive business momentum, making the stock highly speculative with significant downside risk for investors.

Keywords

Biomaterials, Vegan Silk, Beauty and Personal Care, Sustainable Materials, Biotechnology, SEC Filing, Financial Results, Nasdaq Delisting, BSLK, Q2 2025